Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal vs Intramuscular Influenza Vaccine in Healthy Adults
NCT00170547Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Sep 2005
- Primary completion
- Jan 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of Fluzone Trivalent in influenza (4 arms), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoint: Immune Response. Started Sep 2005; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00170547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00170547.